Product Name |
MF |
CAS |
Details |
Aprepitant RRR isomer (diastearomer)-(5-(((2R,3R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)
ethoxy)-3-(4-fluorophenyl)
morpholino)methyl)-1,2-dihydro-1,2,4-triazol-3-one) |
C23H21F7N4O3 |
1148113-53-4 |
|
2-Bromo-pyridine |
C5H4BrN |
109-04-6 |
|
(2S,4aR,6S,7R,8R,8aR)-2-phenyl-6-(phenylthio)hexahydropyrano[3,2-d][1,3]dioxine-7,8-diol |
C19H20O5S |
87508-18-7 |
|
1,3-Di-2-thienyl-2-propanone |
C11H10OS2 |
102787-22-4 |
|
2-Chloro-3-fluoroisonicotinaldehyde |
C6H3ClFNO |
329794-28-7 |
|
1-Ethyl-1H-pyrazole-4-carboxaldehyde |
C6H8N2O |
304903-10-4 |
|
(S)-2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanamide hydrochloride |
C7H14ClN3O2 |
2628280-48-6 |
|
1,4-dibromobut-2-yne |
C4H4Br2 |
2219-66-1 |
|
1,2-Epoxydecane |
C10H20O |
2404-44-6 |
|
1-(3-aminophenyl)ethenone |
C8H9NO |
99-03-6 |
|
1,3-Dimethyl-7-(5-oxohexyl)-1H-purine-2,6(3H,7H)-dione(Lomifylline API). |
C13H18N4O3 |
10226-54-7 |
|
N-(Chloromethyl) phthalimide |
C9H6ClNO2 |
17564-64-6 |
|
2,3,4-trichloroaniline |
C6H4Cl3N |
634-67-3 |
|
Dimethyl piperidine-2,3-dicarboxylate |
C9H15NO4 |
23580-75-8 |
|
D,L-Serine Methyl Ester Hydrochloride |
C4H10ClNO3 |
0/5/19 |
|
Cinacalcet para isomer-(3-(4-(trifluoromethyl)phenyl)-N-((R)-1-(naphthalen-5-yl)ethyl)propan-1-amine or (R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(4-(trifluoromethyl) phenyl)propan-1-amine) |
C22H23ClF3N |
1428118-39-1 |
|
(2,4-Dimethoxy phenyl) acetaldehyde |
C10H12O3 |
33567-62-3 |
|
2-(3-nitrophenyl)acetonitrile |
C8H6N2O2 |
621-50-1 |
|
N3,N3,N6,N6-tetrakis(4-methoxyphenyl)-9H-carbazole-3,6-diamine |
C40H35N3O4 |
1630723-98-6 |
|
4-Chloro-6-ethyl-5-fluoropyrimidine |
C6H6ClFN2 |
137234-74-3 |
|
2-Ethoxyethyl p-toluenesulfonate(Bilastine Intermediate). |
C11H16O4S |
17178-11-9 |
|
4-(Diethylamino)but-2-yn-1-ol |
C8H15NO |
10575-25-4 |
|
Cinacalcet ortho isomer-(3-(2-(trifluoromethyl)phenyl)-N-((R)-1-(naphthalen-5-yl)ethyl)propan-1-amine) |
C22H22F3N |
1431699-53-4 |
|
Sarcosine ethyl ester hydrochloride |
C5H12ClNO2 |
52605-49-9 |
|
Ethyl 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate |
C9H11NO4 |
10350-10-4 |
|
(R)-(−)-2,2-Dimethyl-1,3-dioxolan-4-ylmethyl p-toluene sulfonate, |
C13H18O5S |
23788-74-1 |
|
(R)-(−)-2,2-Dimethyl-1,3-dioxolan-4-ylmethyl p-toluene sulfonate |
C13H18O5S |
23788-74-1 |
|
2,5-Dichlorobenzenesulfonyl chloride |
C6H3Cl3O2S |
5402-73-3 |
|
1,4-Dimethoxy-2-fluorobenzene |
C8H9FO2 |
82830-49-7 |
|
Ethyl (R)-(-)-2-pyrrolidone-5-carboxylate |
C7H11NO3 |
68766-96-1 |
|
1-(5-Chloropyridin-2-yl)ethanone |
C7H6ClNO |
94952-46-2 |
|
2-Nitropyridin-3-ol |
C5H4N2O3 |
15128-82-2 |
|
Canagliflozin impurity-(2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene) |
C18H14FIS |
898566-17-1 |
|
1-chloro-2-[2-(2-chlorophenyl)vinyl]benzene |
C14H10Cl2 |
25144-38-1 |
|
N-Methyl-N-pentyl-beta-alanine methyl ester |
C10H21NO2 |
744266-99-7 |
|
5-Bromo-3-pyridinemethanol |
C6H6BrNO |
37669-64-0 |
|
Ethyl 1-(4-fluorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylate |
C12H11FN2O3 |
636568-08-6 |
|
3-Methyl-8-quinolinesulfonyl Chloride(Argatroban API Intermediate).Heparin-induced thrombocytopenia (HIT) immunoglobulin G. |
C10H8ClNO2S |
74863-82-4 |
|
(2-amino-4-methylphenyl)methanol |
C8H11NO |
81335-87-7 |
|
(4-((Allyloxy)methyl)phenyl)methanol |
C11H14O2 |
350671-25-9 |
|
2-Amino-4-chloropyridine |
C5H5ClN2 |
19798-80-2 |
|
5-Nitro-1H-1,2,3-triazole |
C2H2N4O2 |
14544-45-7 |
|
1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole
(Bilastine Intermediate). |
C33H39NO4 |
154477-55-1 |
|
Tetraacetyl canagliflozin |
C32H33FO9S |
866607-35-4 |
|
2-Bromo-3,3-dimethylbutanoic acid |
C6H11BrO2 |
50364-40-4 |
|
(R)-2,5-dioxopyrrolidin-1-yl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanoate |
C24H24N2O6 |
1342820-49-8 |
|
BOC-L-lysine methyl ester. HCl |
C12H25ClN2O4 |
2389-48-2 |
|
2-Chloro-4-hydroxy-benzaldehyde |
C7H5ClO2 |
56962-11-9 |
|
Iodomethyl acetate |
C3H5IO2 |
13398-11-3 |
|
4-Nitrosalicylaldehyde |
C7H5NO4 |
2460-58-4 |
|
(E)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol |
C10H19BO3 |
117924-31-9 |
|
Cinacalcet Naphthyl impurity- ((R)-N-methyl-1-(naphthalen-5-yl)ethanamine hydrochloride) |
C13H15N |
15297-33-3 |
|
2-(4-Bromophenyl)-2-methylpropionic acid(Bilastine Intermediate). |
C10H11BrO2 |
32454-35-6 |
|
3a,4,7,7a-Tetrahydro-4,7-epoxyisobenzofuran-1,3-dione |
C8H6O4 |
0/5/26 |
|
1-(3-Butyn-1-yl)-α,α-diphenyl-4-piperidinemethanol(Fexofenadine Intermediate -Step-2) |
C22H25NO |
476468-82-3 |
|
3-Fluoro nitrobenzene |
C6H4FNO2 |
402-67-5 |
|
3,5-Difluoro mandelic acid |
C8H6F2O3 |
132741-31-2 |
|
2-amino-5-bromo-4- Chloropyridine |
C5H4BrClN2 |
942947-94-6 |
|
2-(2-(2,2,2-Trifluoroethoxy)phenoxy)ethyl methanesulfonate.
(Silodosin-Intermediate). |
C11H13F3O5S |
160969-03-9 |
|
5-amino-1H-pyrazole-4-carbonitrile |
C4H4N4 |
1204396-41-7 |
|
But-3-yn-1-yl methanesulfonate(Fexofenadine Intermediate -Step-1) |
C5H8O3S |
72486-09-0 |
|
tert-Butyl (2-aminoethyl)((tributylstannyl)methyl)carbamate |
C20H44N2O2Sn |
1557287-99-6 |
|
1-bromo-4-chloro-2-iodobenzene |
C6H3BrClI |
148836-41-3 |
|
Pralidoxime Chloride-API[PAM.Cl] |
C7H9ClN2O |
51-15-0 |
|
1-isobutyl-1,5-dihydro-imidazo[4,5-a]quinoline-4-one |
C14H15N3O |
99010-99-8 |
|
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycine 1,1-dimethylethyl ester |
C21H23NO4 |
35661-42-8 |
|
Triacetyl impurity |
C27H31ClO9 |
1443341-94-3 |
|
4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one hydrogen chloride |
C22H25Cl2N3O |
37932-96-0 |
|
3-Fluoro-4-nitrobenzoic acid |
C7H4FNO4 |
403-21-4 |
|
2,4-Diamino-6-Chloro Pyridine |
C4H5ClN4 |
156-83-2 |
|
Dimethyl 1,3-acetone dicarboxylate |
C7H10O5 |
1830-54-2 |
|
Azelastine Hydrochloride |
C22H25Cl2N3O |
79307-93-0 |
|
N-Cbz-R-4-Hydroxyphenylglycine |
C16H15NO5 |
26787-75-7 |
|
methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((R)-2-oxopyrrolidin-3-yl)propanoate |
C13H22N2O5 |
328086-60-8 |
|
5-Amino-2-methoxy pyridine |
C6H8N2O |
6628-77-9 |
|
2,3,4,5-Tetrachloroaniline |
C6H3Cl4N |
634-83-3 |
|
Hexahydro-4,7-epoxyisobenzofuran-1,3-dione |
C8H8O4 |
0/6/42 |
|
Methyl phenyl sulfone |
C7H8O2S |
3112-85-4 |
|
2-(2-Hydroxyethoxy)phenol
(Tosylated Silodosin-Intermediate) |
C8H10O3 |
4792-78-3 |
|
2-(2-Hydroxyethoxy)phenol(Silidosine Intermediate). |
C8H10O3 |
4792-78-3 |
|
Cinacalcet regioisomer-(3-(3-(trifluoromethyl)phenyl)-N-(1-(naphthalen-6-yl)ethyl)propan-1-amine) |
C22H22F3N |
2074615-22-6 |
|
Tetraphenyl ethylene |
C26H20 |
632-51-9 |
|
(4s,4as,5ar,12as)-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-naphthacenecarboxamide |
C21H22N2O7 |
808-26-4 |
|
4-(3-Methylphenyl)Amino-3-Pyridinesulfonamide
(Torsemide Intermediate) |
C12H13N3O2S |
72811-73-5 |
|
5-Amino-2-chloropyridine |
C5H5ClN2 |
5350-93-6 |
|
2-Bromo-1,3,5-triisopropylbenzene |
C15H23Br |
21524-34-5 |
|
3-[(Methoxycarbonyl)amino]propanoic acid |
C5H9NO4 |
158213-81-1 |
|
Cyclosporine-A |
C62H111N11O15S |
121673-00-5 |
|
6-(Chloromethyl)-11H-dibenz[b,e]azepine |
C15H12ClN |
21535-44-4 |
|
1-methylsulfonylpiperidin-3-amine |
C6H14N2O2S |
934107-80-9 |
|
3,5-Bisacetyloxy benzoyl chloride |
C11H9ClO5 |
39192-49-9 |
|
N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide
(Torsemide Intermediate) |
C16H20N4O3S |
56211-40-6 |
|
3-Acetone di carboxylic acid |
C5H6O5 |
542-05-2 |
|
3,5-Dibromo-4H-1,2,4-triazole |
C2HBr2N3 |
7411-23-6 |
|
1-Bromo-2-chloro-benzene |
C6H4BrCl |
694-80-4 |
|
4-AMINO-3,5-DICHLORO-2-METHYLPYRIDINE |
C6H6Cl2N2 |
195045-26-2 |
|
2-(2-Methylanilino)nicotinic acid |
C13H12N2O2 |
17782-05-7 |
|
Desfluoro aprepitant(5-([(2R,3S)-2-((R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy)-3-phenyl morpholino]methyl)-1H-1,2,4-triazol-3(2H)-one) |
C23H22F6N4O3 |
170729-76-7 |
|
3-Hydroxy-3-methylbutyl 4-methylbenzene sulfonate |
C12H18O4S |
17689-66-6 |
|
7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-1-(hydroxymethyl)-3,4-dihydroquinolin-2(1H)-one |
C24H29Cl2N3O3 |
1259312-25-8 |
|